{"id":"https://openalex.org/W2561488745","doi":null,"title":"Antimicrobial resistance patterns among Acinetobacter baumannii isolated from burn intensive care unit in Tripoli, Libya","display_name":"Antimicrobial resistance patterns among Acinetobacter baumannii isolated from burn intensive care unit in Tripoli, Libya","publication_year":2012,"publication_date":"2012-10-22","ids":{"openalex":"https://openalex.org/W2561488745","mag":"2561488745"},"language":"en","primary_location":{"id":"mag:2561488745","doi":null,"is_oa":false,"landing_page_url":"http://imed.pub/ojs/index.php/IAJAA/article/download/486/369","pdf_url":null,"source":{"id":"https://openalex.org/S2764811353","display_name":"The International Arabic Journal of Antimicrobial Agents","issn_l":"2174-9094","issn":["2174-9094"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"The International Arabic Journal of Antimicrobial Agents","raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5009396068","display_name":"Hisham M. Ziglam","orcid":"https://orcid.org/0000-0001-5562-7693","observed_orcids":["https://orcid.org/0000-0001-5562-7693"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hisham Ziglam","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-5562-7693","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036057429","display_name":"Omar Elahmer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Omar Elahmer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110212881","display_name":"Samira Amri","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Samira Amri","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056856677","display_name":"Fatima Shareef","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fatima Shareef","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058393458","display_name":"Ali Grera","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ali Grera","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046282207","display_name":"Mohamed Labeeb","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mohamed Labeeb","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5111014557","display_name":"Abdulaziz Zorgani","orcid":"https://orcid.org/0000-0002-6219-5427","observed_orcids":["https://orcid.org/0000-0002-6219-5427"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Abdulaziz Zorgani","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.1742,"has_fulltext":false,"cited_by_count":8,"citation_normalized_percentile":{"value":0.58632029,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"2","issue":"3","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10897","display_name":"Antibiotic Use and Resistance","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12824","display_name":"Infections and bacterial resistance","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/acinetobacter-baumannii","display_name":"Acinetobacter baumannii","score":1.0},{"id":"https://openalex.org/keywords/antimicrobial-resistance","display_name":"antimicrobial resistance","score":0.9940000176429749},{"id":"https://openalex.org/keywords/multidrug-resistance","display_name":"multidrug resistance","score":0.9089999794960022},{"id":"https://openalex.org/keywords/burn-intensive-care-unit","display_name":"burn intensive care unit","score":0.9020000100135803},{"id":"https://openalex.org/keywords/carbapenem-resistance","display_name":"carbapenem resistance","score":0.9300000071525574},{"id":"https://openalex.org/keywords/imipenem","display_name":"imipenem","score":0.9269999861717224},{"id":"https://openalex.org/keywords/meropenem","display_name":"meropenem","score":1.0},{"id":"https://openalex.org/keywords/carbapenemase","display_name":"carbapenemase","score":0.6919999718666077},{"id":"https://openalex.org/keywords/nosocomial-infections","display_name":"nosocomial infections","score":0.6110000014305115},{"id":"https://openalex.org/keywords/cross-transmission","display_name":"cross-transmission","score":0.5910000205039978},{"id":"https://openalex.org/keywords/tripoli-libya","display_name":"Tripoli, Libya","score":0.8019999861717224}],"concepts":[{"id":"https://openalex.org/C2779375183","wikidata":"https://www.wikidata.org/wiki/Q421670","display_name":"Meropenem","level":4,"score":0.883456826210022},{"id":"https://openalex.org/C2779631663","wikidata":"https://www.wikidata.org/wiki/Q425152","display_name":"Imipenem","level":4,"score":0.8127126693725586},{"id":"https://openalex.org/C2776315533","wikidata":"https://www.wikidata.org/wiki/Q3241189","display_name":"Acinetobacter baumannii","level":4,"score":0.7723823189735413},{"id":"https://openalex.org/C2778719061","wikidata":"https://www.wikidata.org/wiki/Q417968","display_name":"Cefotaxime","level":3,"score":0.625807523727417},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6139006614685059},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.567898690700531},{"id":"https://openalex.org/C2777427914","wikidata":"https://www.wikidata.org/wiki/Q408529","display_name":"Amikacin","level":3,"score":0.5217586159706116},{"id":"https://openalex.org/C94665300","wikidata":"https://www.wikidata.org/wiki/Q63391344","display_name":"Antibiotic resistance","level":3,"score":0.512416660785675},{"id":"https://openalex.org/C2777050379","wikidata":"https://www.wikidata.org/wiki/Q2552927","display_name":"Cefepime","level":5,"score":0.4986419677734375},{"id":"https://openalex.org/C2776968632","wikidata":"https://www.wikidata.org/wiki/Q808845","display_name":"Ceftazidime","level":4,"score":0.47172823548316956},{"id":"https://openalex.org/C2778512257","wikidata":"https://www.wikidata.org/wiki/Q256602","display_name":"Ciprofloxacin","level":3,"score":0.45149797201156616},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.38920915126800537},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.24346956610679626},{"id":"https://openalex.org/C2777637488","wikidata":"https://www.wikidata.org/wiki/Q31856","display_name":"Pseudomonas aeruginosa","level":3,"score":0.1111014187335968},{"id":"https://openalex.org/C523546767","wikidata":"https://www.wikidata.org/wiki/Q10876","display_name":"Bacteria","level":2,"score":0.08229228854179382},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2561488745","doi":null,"is_oa":false,"landing_page_url":"http://imed.pub/ojs/index.php/IAJAA/article/download/486/369","pdf_url":null,"source":{"id":"https://openalex.org/S2764811353","display_name":"The International Arabic Journal of Antimicrobial Agents","issn_l":"2174-9094","issn":["2174-9094"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"The International Arabic Journal of Antimicrobial Agents","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7045363250","https://openalex.org/W2348150956","https://openalex.org/W2560128804","https://openalex.org/W2301275882","https://openalex.org/W4390908864","https://openalex.org/W2946451893","https://openalex.org/W347195562","https://openalex.org/W2388707312","https://openalex.org/W2322448393","https://openalex.org/W2384170137"],"abstract_inverted_index":{"Background:":[0],"Acinetobacter":[1,39],"baumannii":[2,40,85,174],"is":[3],"a":[4,19],"troublesome":[5],"and":[6,68,133,152,160,176,181,195],"increasingly":[7],"problematic":[8],"healthcare-associated":[9],"pathogen,":[10],"especially":[11],"in":[12,24,124,183,210],"critical":[13],"care":[14],"unit.":[15],"These":[16],"organisms":[17],"have":[18],"capacity":[20],"for":[21],"long-term":[22],"survival":[23],"the":[25,34,95,103,117,167],"hospital":[26,191],"environment.":[27],"Aim:":[28],"This":[29],"study":[30,96],"aimed":[31],"to":[32,55,99,128,130,137,149,179,189,204],"investigates":[33],"drug":[35],"resistance":[36,125,148,172,178],"patterns":[37],"of":[38,52,83,147,170],"strains":[41,158],"isolated":[42],"from":[43,97,126,135],"burn":[44],"ICU":[45,141],"(BICU).":[46],"Method:":[48],"The":[49,80],"antibiotic":[50,107,197],"susceptibility":[51],"176":[53],"isolates":[54,86,90,111,142],"imipenem,":[56],"meropenem,":[57],"gentamicin,":[58],"ciprofloxacin,":[59],"fusidic":[60],"acid,":[61],"amikacin,":[62],"trimethoprim,":[63],"cefepime,":[64],"ceftazidime,":[65],"ceftriaxone,":[66],"cefotaxime,":[67],"amoxicillin-calvulanic":[69],"acid":[70],"was":[71,121],"determined":[72],"by":[73],"disk":[74],"agar":[75],"diffusion":[76],"test.":[77],"Findings:":[79],"overall":[81],"proportion":[82],"A.":[84,109,173],"among":[87],"all":[88],"clinical":[89],"has":[91],"increased":[92,177],"slightly":[93],"throughout":[94],"3.5%":[98],"4.2%.":[100],"Carpabenem":[101],"remained":[102],"antimicrobial":[104],"most":[105],"active":[106],"against":[108],"braumannii":[110],"compared":[112,155],"with":[113,156],"other":[114],"antibiotics,":[115],"during":[116],"two":[118],"years":[119],"there":[120],"an":[122],"increase":[123],"50.6%":[127,136],"71.3%":[129],"imipenem":[131,150,180],"(P<0.01),":[132],"meropenem":[134,153,182],"74.5%":[138],"(P<0.01).":[139,163],"exhibited":[143],"significantly":[144],"higher":[145],"level":[146],"(71.6%)":[151],"(73.4%)":[154],"non-ICU":[157],"(42.6%":[159],"44.6%":[161],"respectively)":[162],"Conclusion:":[164],"In":[165],"conclusion,":[166],"high":[168],"prevalence":[169],"multidrug":[171],"(97.7%)":[175],"our":[184],"unit":[185],"might":[186],"be":[187],"due":[188],"long":[190],"stay,":[192],"intubation,":[193],"surgery":[194],"previous":[196],"prescription.":[198],"It":[199],"would":[200],"seem":[201],"that":[202],"practices":[203],"prevent":[205],"cross-transmission":[206],"are":[207],"more":[208],"important":[209],"controlling":[211],"resistance.":[212]},"counts_by_year":[{"year":2021,"cited_by_count":3},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":3},{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2017-01-06T00:00:00"}